Role of FHIT in human cancer

Journal of Clinical Oncology

Volumn 17, Issue 5, 1999, Pages 1618-1624

  Croce, Carlo M ^a   Sozzi, Gabriella ^a   Huebner, Kay ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CARCINOGENESIS; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE LOCATION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032948557     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.5.1618     Document Type: Article

References (31)

1. Ar-Rushdi A, Nishikura K, Erikson J, et al: Differential expression of the translocated and of the untranslocated c-myc oncogene in Burkitt lymphoma. Science 222:390-393, 1983
2. Tsujimoto Y, Cossman J, Jaffe E, et al: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443, 1985
3. Arakawa H, Nakamura T, Zhadanov AB, et al: Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene. Proc Natl Acad Sci U S A 95:4573-4578, 1998
4. Naylor SL, Johnson BE, Minna JD, et al: Loss of heterozygosity of chromosome 3p markers in small cell lung cancer. Nature 329:451-454, 1987
5. Rabbitts P, Doughlas J, Daly M, et al: Frequency and extent of allelic loss in the short arm of chromosome 3 in non small cell lung cancer. Genes Chromosom Cancer 9:95-105, 1989
6. Hibi K, Takahashi T, Yamakawa K, et al: Three distinct regions involved in 3p deletions in human lung cancer. Oncogene 7:445-449, 1992
7. Huebner K, Hadaczek P, Siprashvili Z, et al: The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FRA3B. Biochim Biophys Acta (Reviews on Cancer) 1332:M65-M70, 1997
8. Ohta M, Inoue H, Cotticelli MG, et al: The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal cell carcinoma associated translocation breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597, 1996
9. Yunis JJ, Soreng AL: Constitutive fragile sites and cancers. Science 226:1199-1204, 1984
10. 3 triphosphate hydrolase. Biochemistry 35:11529-11535, 1996
11. Druck T, Hadaczek P, Fu TB, et al: Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 57:504-512, 1997
12. Sozzi G, Veronese ML, Negrini M, et al: The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:17-26, 1996
13. Negrini M, Monaco C, Vorechovsky I, et al: The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:3173-3179, 1996
14. Virgilio L, Shuster M, Gollin SM, et al: FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U S A 93:9770-9775, 1996
15. Greenspan DL, Connolly DC, Wu R, et al: Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 37:4692-4698, 1997
16. Simon B, Bartsch D, Earth P, et al: Frequent abnormalities of the putative tumor suppressor gene FHITat 3p14.2 in pancreatic carcinoma cell lines. Cancer Res 58:1583-1587, 1998
17. Inoue H, Ishii H, Alder H, et al: Sequence of the FRA3B common fragile region: Implications for the mechanisms of FHIT deletion. Proc Natl Acad Sci U S A 94:14584-14589, 1997
18. Baffa R, Veronese ML, Santoro R, et al: Loss of FHITexpression in gastric carcinoma. Cancer Res 58:4708-4714, 1998
19. Sozzi G, Sard L, DeGregorio L, et al: Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 57:2121-2123, 1998
20. Nelson HH, Wiencke JK, Gunn L, et al: Chromosome 3p14 alterations in lung cancer: Evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 58:1804-1807, 1998
21. Zimonjic, DB, Druck T, Ohta M, et al: Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res 57:1166-1170, 1997
22. Boldog FL, Gemmill RM, West J, et al: Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 6:193-203, 1997
23. Sozzi G, Tornielli S, Tagliabue E, et al: Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res 57:5207-5212, 1997
24. Sozzi G, Pastorino U, Moiraghi L, et al: Loss of FHIT function in lung cancer and preinvasive bronchila lesions. Cancer Res 58:5032-5037, 1998
25. Mao L, Lee JS, Kurie JM, et al: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89:857-862, 1997
26. Wistuba II, Lam S, Behrens C, et al: Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89:1366-1373, 1997
27. Siprashvili Z, Sozzi G, Barnes LD, et al: Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A 94:13771-13776, 1997
28. Pace HC, Garrison PN, Robinson AK, et al: Genetic, biochemical and crystallographic characterization of Fhit-substrate complexes as the active, signaling form of Fhit. Proc Natl Acad Sci U S A 95:5484-5489, 1998
29. Otterson GA, Xiao G-H, Geradts J, et al: Protein expression and functional analysis of the FHIT gene in human tumor cells. J Natl Cancer Inst 90:426-432, 1998
30. Pekarsky Y, Campiglio M, Siprashvili Z, et al: Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. Proc Natl Acad Sci U S A 95:8744-8749, 1998
31. Hadaczek P, Siprashvili Z, Markiewski M, et al: Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 58:2946-2951, 1998